We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+21.19%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.77B
AUM Growth
-$20M
Cap. Flow
-$279M
Cap. Flow %
-15.76%
Top 10 Hldgs %
16.25%
Holding
547
New
90
Increased
94
Reduced
221
Closed
118

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$32.2M
2
A icon
Agilent Technologies
A
+$10.1M
3
INCY icon
Incyte
INCY
+$9.9M
4
APC
Anadarko Petroleum
APC
+$9.65M
5
NOW icon
ServiceNow
NOW
+$9.61M

Top Sells

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$22.6M
2
AGN
Allergan plc
AGN
+$19.6M
3
CPRI icon
Capri Holdings
CPRI
+$18.6M
4
DAL icon
Delta Air Lines
DAL
+$17.6M
5
NTNX icon
Nutanix
NTNX
+$17.6M

Sector Composition

Rank Sector Weight
1 Healthcare 26.83%
2 Technology 24.23%
3 Consumer Discretionary 14.95%
4 Industrials 7.4%
5 Financials 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MFC icon
476
Manulife Financial
MFC
$73.1B
– –
-133,491
Closed -$1.89M
MS icon
477
Morgan Stanley
MS
$324B
– –
-570,700
Closed -$22.6M
MSA icon
478
Mine Safety
MSA
$6.75B
– –
-32,818
Closed -$3.09M
MSEX icon
479
Middlesex Water
MSEX
$1.07B
– –
-4,500
Closed -$240K
NTAP icon
480
NetApp
NTAP
$33.9B
– –
-9,052
Closed -$540K
NTLA icon
481
Intellia Therapeutics
NTLA
$1.5B
– –
-87,743
Closed -$1.2M
NTNX icon
482
Nutanix
NTNX
$16B
– –
-423,326
Closed -$17.6M
NWN icon
483
Northwest Natural Holdings
NWN
$2.19B
– –
-14,400
Closed -$871K
OSBC icon
484
Old Second Bancorp
OSBC
$1.3B
– –
-11,591
Closed -$151K
PAHC icon
485
Phibro Animal Health
PAHC
$1.48B
– –
-21,628
Closed -$696K
PFGC icon
486
Performance Food Group
PFGC
$18.1B
– –
-192,498
Closed -$6.21M
PRGO icon
487
Perrigo
PRGO
$1.44B
– –
-262,000
Closed -$10.2M
PTCT icon
488
PTC Therapeutics
PTCT
$6.18B
– –
-277,609
Closed -$9.53M
SAIA icon
489
Saia
SAIA
$10.6B
– –
-23,923
Closed -$1.33M
SFBS
490
ServisFirst Bancshares
SFBS
$4.9B
– –
-23,400
Closed -$746K
SFL icon
491
SFL Corp
SFL
$1.6B
– –
-15,980
Closed -$168K
SPOK icon
492
Spok Holdings
SPOK
$229M
– –
-10,112
Closed -$134K
SRCE icon
493
1st Source
SRCE
$2.19B
– –
-5,387
Closed -$217K
SRPT icon
494
Sarepta Therapeutics
SRPT
$1.61B
– –
-113,400
Closed -$12.4M
SVM
495
Silvercorp Metals
SVM
$2B
– –
-40,999
Closed -$86K
THC icon
496
Tenet Healthcare
THC
$22.3B
– –
-138,800
Closed -$2.38M
THR
497
DELISTED
Thermon Group Holdings
THR
– –
-9,934
Closed -$201K
THRM icon
498
Gentherm
THRM
$1.31B
– –
-25,901
Closed -$1.04M
TPB icon
499
Turning Point Brands
TPB
$1.52B
– –
-13,421
Closed -$365K
TTSH
500
DELISTED
Tile Shop Holdings
TTSH
– –
-76,948
Closed -$422K
18 19
20
21 22

Similar funds

ISS
Intesa Sanpaolo SpA. Turin, Italy $1.69B AUM
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
FACM
Forest Avenue Capital Management Miami, Florida $1.69B AUM 104.84% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
SGI
Summit Global Investments Bountiful, Utah $1.69B AUM 12.13% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

PDT Partners's Q1 2019 Portfolio in Review

As of Q1 2019, PDT Partners held 547 positions worth $1.77B, down 1.1% from $1.79B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

PDT Partners withdrew a net $279M in Q1 2019, closing 118 positions and reducing 221 holdings. Its most notable exit was Morgan Stanley, an estimated $22.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, PDT Partners opened a new position in Bristol-Myers Squibb worth $30.8M.

  • PDT Partners's largest Q1 2019 buy was Bristol-Myers Squibb: 645,994 shares worth $30.8M.
  • PDT Partners added most to Anadarko Petroleum in Q1 2019, an estimated $9.65M increase.
  • PDT Partners's biggest Q1 2019 reduction was Spark Therapeutics, Inc. Common Stock, cutting an estimated $11.6M.
  • PDT Partners fully exited Morgan Stanley in Q1 2019, selling an estimated $22.6M.
  • PDT Partners's ten largest holdings make up 16% of its $1.77B portfolio in Q1 2019.
  • PDT Partners opened 90 new positions and closed 118 in Q1 2019.
  • PDT Partners's portfolio value fell 1.1% quarter-over-quarter to $1.77B.

Based on PDT Partners's 13F filing for Q1 2019, filed 15 May 2019.